TNF inhibitors don't cut ACS risk in arthritis patients

01/3/2012 | MedPage Today (free registration)

Researchers found that tumor necrosis factor inhibitors failed to lower acute coronary syndrome risk among patients with early rheumatoid arthritis enrolled in Sweden's national registry from 1999 to 2007. The anti-TNF drugs did not reduce ACS risk even among patients who responded well to the drugs at three months. The study appears in Arthritis & Rheumatism.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC